R

REGENXBIO

Develops AAV gene delivery therapies

Market Development Director

Field SalesPosted on Nov 8
Full-time

About the Job

Requirements

  • A bachelor's degree (BA/BS) is required.
  • At least 5 years of experience in a commercial, market development, or strategic customer engagement role within biotech or pharma is required.
  • A proven track record in the rare disease space is required, ideally including neuromuscular indications.
  • Experience supporting new product launches in complex therapeutic areas is required.
  • A strong understanding of U.S. healthcare dynamics, market access, and reimbursement pathways is required.
  • Familiarity with account-based models and stakeholder mapping in specialty care is required.
  • The role requires the ability to extract insights from data and apply them to commercial decisions.
  • The role requires communication and stakeholder management skills.
  • The role requires the ability to align cross-functional teams toward shared goals.
  • The role requires high ethical standards, integrity, and a mission-driven approach.
  • The role requires the ability to thrive in a fast-paced, entrepreneurial environment.
  • The role requires initiative and problem-solving capabilities.
  • The role requires willingness and flexibility to travel up to 60% for stakeholder engagements.

Responsibilities

  • Develop and execute targeted engagement strategies for key accounts in assigned regions.
  • Establish the company as a trusted partner in the neuromuscular and rare disease communities.
  • Lead regional business planning aligned with corporate goals and cross-functional priorities.
  • Collaborate with internal stakeholders to synthesize customer insights, inform strategic decisions, and optimize messaging and programs.
  • Ensure adequate resource allocation to drive regional business success.
  • Identify, educate, and align thought leaders to strategic imperatives, and ensure brand initiatives are carried through with thought leaders.
  • Profile treatment centers to assess readiness, patient care models, referral patterns, and logistical infrastructure.
  • Deliver education on company products and attend to end-treatment administration logistics.
  • Identify and address barriers to care, including infusion capacity, billing and coding challenges, and payer dynamics.
  • Support reimbursement readiness and validate regional processes for market access.
  • Cultivate strategic partnerships and referral networks to support launch and market expansion.
  • Define and track key performance indicators to measure launch execution quality and speed.
  • Serve as the primary point of contact for assigned treatment centers, experts, and stakeholders.
  • Drive brand awareness, engagement, and treatment adoption through commercial strategies.
  • Monitor regional trends in competitive, regulatory, and payer landscapes to inform strategy.
  • Ensure execution reflects the needs of patients and providers.

Desired Qualifications

  • An advanced degree (MBA, PhD, or PharmD) is strongly preferred.

About the Company

REGENXBIO

Develops AAV gene delivery therapies

REGENXBIO focuses on gene therapy using its NAV Technology Platform, an adeno-associated virus (AAV) gene delivery system with exclusive rights to more than 100 AAV vectors. The company generates revenue by licensing its platform, collecting royalties, and engaging in collaborations, while also developing its own one-time gene therapies for retinal, rare, and neurodegenerative diseases. Key products in later-stage trials include ABBV-RGX-314 for wet AMD and diabetic retinopathy, RGX-202 for Duchenne muscular dystrophy, and RGX-121 for Hunter syndrome, with a goal to advance five new therapies to pivotal-stage or commercial status by 2025 and FDA review for RGX-121 targeted in early 2026. REGENXBIO differentiates itself by owning a broad AAV vector library and offering end-to-end capabilities—from research to manufacturing—alongside a diversified revenue model that includes royalties, collaborations, and milestones.

Company size
201-500
Company stage
IPO
Headquarters
Rockville, MD
Founded
2009

Recently Posted Jobs

Explore more opportunities at REGENXBIO

See more jobs